Industry news that matters to you.  Learn more

Illumina Selects BioDiscovery’s NxClinical Software for Data Visualization, Management and Interpretation for its CytoSeq ™ assay, an NGS-based Solution for Detection of CNVs, AOH, and SNVs

BioDiscovery, Inc., a leader in innovative genomic data analysis software solutions recently announced a collaborative agreement with Illumina Inc. (NASDAQ: ILMN) to provide BioDiscovery’s NxClinical software as the secondary data analysis and management tool for Illumina’s CytoSeq™ assay. The NxClinical software will be offered with the CytoSeq product to provide an easy-to-use interactive tool for visualization and interpretation of genomic events.